Publications by authors named "Ann Mauer"

Claim this Profile
C
Comparison of Patients' Phenotypes, Guideline-Directed Recommendations Compliance and Rates of Cardiotoxicity between Caribbean and United States Cardio-oncology Programs.
Pamela Piña, Amparo Taveras, Amir Khan, Justin Coyle, Victor Bueno, Ann Mauer

Glob Heart· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial.
Hyman B Muss, Mei-Yin C Polley, Donald A Berry, Heshan Liu, Constance T Cirrincione, Ann M Mauer

J Clin Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical germline diagnostic exome sequencing for hereditary cancer: Findings within novel candidate genes are prevalent.
Zöe Powis, Carin R Espenschied, Holly LaDuca, Kelly D Hagman, Tripti Paudyal, Ann Mauer

Cancer Genet· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction.
Nicholas W Choong, Ann M Mauer, Daniel C Haraf, Mark K Ferguson, Alan B Sandler

Med Oncol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II study of pemetrexed with or without ABT-751 in advanced or metastatic non-small-cell lung cancer.
Charles M Rudin, Ann Mauer, Martin Smakal, Rosalyn Juergens, Stanislav Spelda

J Clin Oncol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant chemotherapy in older women with early-stage breast cancer.
Hyman B Muss, Donald A Berry, Constance T Cirrincione, Maria Theodoulou, Ann M Mauer

N Engl J Med· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancer.
Edward S Kim, Ann M Mauer, William N William, Hai T Tran, Diane Liu

Cancer· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of paclitaxel and cisplatin in patients with extensive stage small cell lung cancer: Cancer and Leukemia Group B Trial 9430.
Thomas E Stinchcombe, Ann M Mauer, Lydia D Hodgson, James E Herndon, Thomas J Lynch

J Thorac Oncol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer.
Nicholas W Choong, Ann M Mauer, Daniel J Haraf, Eric Lester, Philip C Hoffman

J Thorac Oncol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of ABT-751 in patients with advanced non-small cell lung cancer.
Ann M Mauer, Ezra E W Cohen, Patrick C Ma, Mark F Kozloff, Lee Schwartzberg

J Thorac Oncol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203.
Martin J Edelman, Dee Watson, Xiaofei Wang, Carl Morrison, Robert A Kratzke, Ann M Mauer

J Clin Oncol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer.
Nicholas W Choong, Everett E Vokes, Daniel J Haraf, Peter K Tothy, Mark K Ferguson, Ann M Mauer

J Thorac Oncol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of docetaxel based induction and concomitant chemotherapy in patients with locally advanced head and neck cancer.
Tanguy Y Seiwert, Ezra E W Cohen, Daniel J Haraf, Kerstin Stenson, Elizabeth A Blair, Ann Mauer

Cancer Invest· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic value of chromosome 7 polysomy in non-small cell lung cancer patients treated with gefitinib.
Lela E Buckingham, John S Coon, Larry E Morrison, Kristine K B Jacobson, Susan S Jewell, Ann M Mauer

J Thorac Oncol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of cooperative groups in cancer clinical trials.
Ann M Mauer, Elizabeth S Rich, Richard L Schilsky

Cancer Treat Res· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer.
Tanguy Y Seiwert, Philip P Connell, Ann M Mauer, Philip C Hoffman, Christopher M George

Clin Cancer Res· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer.
Athanassios Argiris, Ezra Cohen, Theodore Karrison, Benjamin Esparaz, Ann Mauer

Cancer Biol Ther· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer.
Nicholas W Choong, Ann M Mauer, Philip C Hoffman, Charles M Rudin, Jerome D Winegarden

J Thorac Oncol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Ezra E W Cohen, Madeleine A Kane, Marcy A List, Bruce E Brockstein, Bhoomi Mehrotra, Ann M Mauer

Clin Cancer Res· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of UFT and leucovorin in women 65 years and older with advanced breast cancer.
Supriya Gupta, Ann M Mauer, Christopher W Ryan, David A Taber, Brian L Samuels

Am J Clin Oncol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment.
Neil Mehta, Ann M Mauer, Samuel Hellman, Daniel J Haraf, Ezra E W Cohen

Int J Oncol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I clinical trial of CEP-2563 dihydrochloride, a receptor tyrosine kinase inhibitor, in patients with refractory solid tumors.
Samir D Undevia, Nicholas J Vogelzang, Ann M Mauer, Linda Janisch, Sridhar Mani

Invest New Drugs· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of the farnesyl transferase inhibitor R115777 in patients with advanced non-small-cell lung cancer.
Alex A Adjei, Ann Mauer, Laura Bruzek, Randolph S Marks, Shauna Hillman

J Clin Oncol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of bryostatin-1 and paclitaxel in patients with advanced non-small cell lung cancer.
Jerome D Winegarden, Ann M Mauer, Thomas F Gajewski, Philip C Hoffman, Stuart Krauss

Lung Cancer· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of dose-dense alternating doublets in advanced non-small-cell lung cancer.
Everett E Vokes, Chaiyut Charoentum, Gary S Gordon, Charles M Rudin, Stuart A Krauss, Ann M Mauer

Clin Lung Cancer· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis